Cardiac side effects are a major drawback of anticancer therapies, often requiring the use of
low and less effective doses or even discontinuation of the drug. Among all the drugs known …

Anthracyclines, such as doxorubicin, represent one group of chemotherapy drugs with the
most cardiotoxicity. Despite that anthracyclines are capable of treating assorted solid tumors …

Anthracyclines remain the cornerstone in the treatment of many malignancies including
lymphomas, leukaemias, and sarcomas. Unfortunately, the clinical use of these potent …

Anthracyclines is an effective chemotherapeutic treatment used for many types of cancer.
However, high cumulative dosage of anthracyclines leads to cardiac toxicity and heart …

Significance: The cardiac side effects of hematological treatments are a major issue of the
growing population of cancer survivors, often affecting patient survival even more than the …

Anthracycline antineoplastic agents such as doxorubicin are widely used and highly
effective component of adjuvant chemotherapy for breast cancer and curative regimens for …

Anthracycline‐induced cardiotoxicity (AIC) persists as a significant cause of morbidity and
mortality in cancer survivors. Although many protective strategies have been evaluated …

Anthracycline-based chemotherapy can result in the development of a cumulative and
progressively developing cardiomyopathy. Doxorubicin is one of the most highly prescribed …

Anthracyclines are common chemotherapeutic agents used to treat many different types of
cancer. Unfortunately, the use of anthracyclines is limited by their cardiotoxic effects, which …

Anthracyclines have contributed significantly to remarkable improvements in overall survival
and are regarded as the most effective cytostatic drug for cancer treatment in various …